View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 1, 2021

Althea introduces affordable Covid-19 antigen tests

Medical technology services provider Althea UK and Ireland has launched high-quality and cost-effective SARS-CoV-2 rapid antigen tests.

Medical technology services provider Althea UK and Ireland has launched high-quality and cost-effective SARS-CoV-2 rapid antigen tests.

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

Manufactured by Roche , the antibody test can help identify SARS-CoV-2 infection in suspected people and can deliver results in 15 minutes.

It is a rapid chromatographic immunoassay, which uses nasopharyngeal swab samples for testing and has a sensitivity of 96.52% and specificity of 99.68%.

In addition, the test can be used for symptomatic and asymptomatic individuals.

The company noted that the latest service, which is accessible for pharmacies, dentists, hospitals, clinics, and hospital support companies whose staff access clinical settings, will offer a valuable initial screening test for staff who are possibly exposed to Covid-19 or work in high-risk settings.

Althea CEO David Rolfe said: “As Covid-19 continues to spread and while vaccinations are being rolled out, testing remains crucial to contain the spread of Covid-19.

“We are pleased to be able to offer the Roche rapid antigen tests to support those providing vital services across the country with a reliable, high-quality testing option at an affordable price.

“At a time where budgets are stretched and health services are under pressure, as a trusted partner to many hospitals in the UK, we want to do our part in supporting those working on the frontline.”

The company manages and maintains medical technology in hospitals and is entirely vendor-independent, meaning they can combine the best technology from across all manufacturers.

Althea noted that during Covid-19, it performed a major role in setting up equipment at the London NHS Nightingale Hospital, which was established to provide emergency care to Covid-19 patients.

Currently, the company offers rapid Covid-19 tests to help further support the national response to the pandemic.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network